These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26307779)

  • 1. Access to flucytosine for HIV-infected patients with cryptococcal meningitis – an urgent need.
    Govender NP; Meintjes G; Banoo S
    S Afr Med J; 2014 Sep; 104(9):594-5. PubMed ID: 26307779
    [No Abstract]   [Full Text] [Related]  

  • 2. Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
    Milani B; Ford N
    S Afr Med J; 2012 Mar; 102(4):196-7. PubMed ID: 22464494
    [No Abstract]   [Full Text] [Related]  

  • 3. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
    Loyse A; Dromer F; Day J; Lortholary O; Harrison TS
    J Antimicrob Chemother; 2013 Nov; 68(11):2435-44. PubMed ID: 23788479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
    Bicanic T; Wood R; Bekker LG; Darder M; Meintjes G; Harrison TS
    Lancet Infect Dis; 2005 Sep; 5(9):530-1. PubMed ID: 16122672
    [No Abstract]   [Full Text] [Related]  

  • 5. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
    Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating cryptococcal meningitis in people with HIV.
    BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
    [No Abstract]   [Full Text] [Related]  

  • 7. Ending deaths from HIV-related cryptococcal meningitis by 2030.
    Shroufi A; Chiller T; Jordan A; Denning DW; Harrison TS; Govender NP; Loyse A; Baptiste S; Rajasingham R; Boulware DR; Ribeiro I; Jarvis JN; Van Cutsem G
    Lancet Infect Dis; 2021 Jan; 21(1):16-18. PubMed ID: 33271065
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of cryptococcal meningitis.
    Zingman BS
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380128
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS patients in South Africa to get free drug.
    Sidley P
    BMJ; 2000 Apr; 320(7242):1095. PubMed ID: 10775213
    [No Abstract]   [Full Text] [Related]  

  • 11. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of cryptococcal meningitis.
    Larsen RA
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380127
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
    Merry M; Boulware DR
    Clin Infect Dis; 2016 Jun; 62(12):1564-8. PubMed ID: 27009249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries.
    Loyse A; Thangaraj H; Easterbrook P; Ford N; Roy M; Chiller T; Govender N; Harrison TS; Bicanic T
    Lancet Infect Dis; 2013 Jul; 13(7):629-37. PubMed ID: 23735626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
    Riantawan P; Ponglertnapakorn P
    J Med Assoc Thai; 1996 Jul; 79(7):429-33. PubMed ID: 8855621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcal meningitis in pediatric AIDS.
    Kaur R; Rawat D; Kakkar M; Monga R; Sharma VK
    J Trop Pediatr; 2003 Apr; 49(2):124-5. PubMed ID: 12729297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa.
    Miot J; Leong T; Takuva S; Parrish A; Dawood H
    BMC Health Serv Res; 2021 Apr; 21(1):305. PubMed ID: 33823842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme.
    Shroufi A; Govender NP; Meintjes G; Black J; Nel J; Moosa MS; Menezes C; Dawood H; Wilson D; Duran LT; Ajose O; Murphy RA; Harrison T; Loyse A; Ruffell C; Van Cutsem G
    Int J Infect Dis; 2020 Jun; 95():459-461. PubMed ID: 32126322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans var. gattii meningitis in an HIV-positive patient: first observation in the United Kingdom.
    Bodasing N; Seaton RA; Shankland GS; Kennedy D
    J Infect; 2004 Oct; 49(3):253-5. PubMed ID: 15337344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.